Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-b58lm Total loading time: 0 Render date: 2025-05-05T00:22:12.891Z Has data issue: false hasContentIssue false

15 - Proteolytic Cascades in Invasion and Metastasis

from STROMAL CELLS/EXTRACELLULAR MATRIX

Published online by Cambridge University Press:  05 June 2012

By
Steven D. Mason  and
Johanna A. Joyce
Edited by
David Lyden ,
Danny R. Welch  and
Bethan Psaila
Steven D. Mason
Affiliation:
Memorial Sloan-Kettering Cancer Center, United States
Johanna A. Joyce
Affiliation:
Memorial Sloan-Kettering Cancer Center, United States
David Lyden
Affiliation:
Weill Cornell Medical College, New York
Danny R. Welch
Affiliation:
Weill Cornell Medical College, New York
Bethan Psaila
Affiliation:
Imperial College of Medicine, London
Get access

Summary

During tumor progression, there are several key stages that require the action of proteases (Figure 15.1). First, the induction of angiogenesis, or new blood vessel growth, involves degradation of the vascular basement membrane and the release and/or activation of matrix-bound proangiogenic growth factors. Second, invasion of cancer cells into the surrounding tissue requires the dissolution of cell–cell junctions and degradation of the epithelial basement membrane/extracellular matrix (BM/ECM) for cancer cells to spread from the primary tumor. Third, at least two key steps in metastasis require proteolysis: intravasation of cancer cells into the blood or lymphatic circulation at the primary site, and extravasation at the secondary site, where proteases can again play a role in promoting the colonization and growth of cancer cells as they do in the primary tumor.

Proteases not only are essential for the degradation of BM/ECM proteins, however; they also have more specialized processing roles that are important for cell signaling, such as in the restricted cleavage of pro-domains and subsequent activation of growth factors and cytokines. These functions are tightly regulated in a cascade of proteolytic interactions, allowing for control and amplification of proteolysis in metastasis.

The realization that proteolysis is necessary for multiple stages in metastasis emphasizes the importance of identifying the key tumor-promoting proteases, determining how individual proteases interact with each other, and developing therapeutic strategies to inhibit their actions.

Type
Chapter
Information
Cancer Metastasis
Biologic Basis and Therapeutics
 , pp. 167 - 182
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Zucker, S et al. (2000) Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene. 19: 6642.CrossRefGoogle ScholarPubMed
Coussens, LM et al. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 295: 2387.CrossRefGoogle ScholarPubMed
Vihinen, P et al. (2005) Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 5: 203.CrossRefGoogle Scholar
Caravita, T et al. (2006) Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies. Nat Clin Pract Oncol. 3: 374.CrossRefGoogle ScholarPubMed
Palermo, C, Joyce, JA (2008) Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci. 29: 22.CrossRefGoogle Scholar
Lopez-Otin, C, Matrisian, LM (2007) Emerging roles of proteases in tumour suppression. Nat Rev Cancer. 7: 800.CrossRefGoogle ScholarPubMed
Soung, YH et al. (2004) Somatic mutations of CASP3 gene in human cancers. Hum Genet. 115: 112.CrossRefGoogle ScholarPubMed
Offman, J et al. (2005) Repeated sequences in CASPASE-5 and FANCD2 but not NF1 are targets for mutation in microsatellite-unstable acute leukemia/myelodysplastic syndrome. Mol Cancer Res. 3: 251.CrossRefGoogle Scholar
Lee, JW et al. (2006) Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas. APMIS. 114: 646.CrossRefGoogle ScholarPubMed
Soung, YH et al. (2003) Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene. 22: 8048.CrossRefGoogle ScholarPubMed
Lopez-Otin, C, Overall, CM (2002) Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol. 3: 509.CrossRefGoogle ScholarPubMed
Lane, DA et al. (2005) Directing thrombin. Blood. 106: 2605.CrossRefGoogle ScholarPubMed
Gabrijelcic, D et al. (1992) Cathepsins B, H and L in human breast carcinoma. Eur J Clin Chem Clin Biochem. 30: 69.Google ScholarPubMed
Liaudet-Coopman, E et al. (2006) Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 237: 167.CrossRefGoogle ScholarPubMed
Rochefort, H et al. (1989) Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem. 34: 177.CrossRefGoogle ScholarPubMed
Cavailles, V et al. (1993) Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci U S A 90: 203.CrossRefGoogle ScholarPubMed
Laurent-Matha, V et al. (2005) Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J Cell Biol. 168: 489.CrossRefGoogle ScholarPubMed
Krishnamachary, B et al. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63: 1138.Google ScholarPubMed
Hu, L et al. (2008) Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res. 68: 4666.CrossRefGoogle ScholarPubMed
Capony, F et al. (1987) Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J Cell Biol. 104: 253.CrossRefGoogle ScholarPubMed
Figura, K, Hasilik, A (1986) Lysosomal enzymes and their receptors. Annu Rev Biochem. 55: 167.CrossRefGoogle Scholar
Kornfeld, S (1990) Lysosomal enzyme targeting. Biochem Soc Trans. 18: 367.CrossRefGoogle ScholarPubMed
Larsen, LB et al. (1993) Procathepsin D cannot autoactivate to cathepsin D at acid pH. FEBS Lett. 319: 54.CrossRefGoogle ScholarPubMed
Stappen, JW et al. (1996) Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer 67: 547.3.0.CO;2-4>CrossRefGoogle Scholar
Lenarcic, B et al. (1988) Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. Biochem Biophys Res Commun. 154: 765.CrossRefGoogle ScholarPubMed
Capony, F et al. (1989) Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res. 49: 3904.Google ScholarPubMed
Rochefort, H (1992) Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer. 28A: 1780.CrossRefGoogle Scholar
Westley, BR, May, FE (1999) Prognostic value of cathepsin D in breast cancer. Br J Cancer. 79: 189.CrossRefGoogle ScholarPubMed
Foekens, JA et al. (1999) Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer. 79: 300.CrossRefGoogle ScholarPubMed
Selicharova, I et al. (2008) 2-DE analysis of breast cancer cell lines 1833 and 4175 with distinct metastatic organ-specific potentials: comparison with parental cell line MDA-MB-231. Oncol Rep. 19: 1237.Google ScholarPubMed
Li, DQ et al. (2006) Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics. 6: 3352.CrossRefGoogle Scholar
Glondu, M et al. (2002) Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene. 21: 5127.CrossRefGoogle ScholarPubMed
Yan, S et al. (2000) Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma. DNA Cell Biol. 19: 79.CrossRefGoogle ScholarPubMed
Dittmer, J (2003) The biology of the Ets1 proto-oncogene. Mol Cancer. 2: 29.CrossRefGoogle ScholarPubMed
Berquin, IM et al. (1999) Differentiating agents regulate cathepsin B gene expression in HL-60 cells. J Leukoc Biol. 66: 609.CrossRefGoogle ScholarPubMed
Berquin, IM et al. (1995) Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene. Gene. 159: 143.CrossRefGoogle ScholarPubMed
Yan, S, Sloane, BF (2003) Molecular regulation of human cathepsin B: implication in pathologies. Biol Chem. 384: 845.CrossRefGoogle ScholarPubMed
Dickinson, DP (2002) Salivary (SD-type) cystatins: over one billion years in the making – but to what purpose? Crit Rev Oral Biol Med. 13: 485.CrossRefGoogle ScholarPubMed
Szpaderska, AM et al. (2004) Sp1 regulates cathepsin B transcription and invasiveness in murine B16 melanoma cells. Anticancer Res. 24: 3887.Google ScholarPubMed
Sameni, M et al. (2000) Imaging proteolysis by living human breast cancer cells. Neoplasia. 2: 496.CrossRefGoogle ScholarPubMed
Sameni, M et al. (2003) Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Mol Imaging. 2: 159.CrossRefGoogle ScholarPubMed
Campo, E et al. (1994) Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol. 145: 301.Google ScholarPubMed
Castiglioni, T et al. (1994) Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol. 25: 857.CrossRefGoogle ScholarPubMed
Sinha, AA et al. (1993) Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat Rec. 235: 233.CrossRefGoogle ScholarPubMed
Huh, CG et al. (1999) Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol. 52: 332.CrossRefGoogle ScholarPubMed
Cox, JL et al. (1999) Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res. 9: 369.CrossRefGoogle ScholarPubMed
Kopitz, C et al. (2005) Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host. Cancer Res 65: 8608.CrossRefGoogle Scholar
Seth, P et al. (2003) Transcription of human cathepsin L mRNA species hCATL B from a novel alternative promoter in the first intron of its gene. Gene. 321: 83.CrossRefGoogle ScholarPubMed
Arora, S, Chauhan, SS (2002) Identification and characterization of a novel human cathepsin L splice variant. Gene. 293: 123.CrossRefGoogle ScholarPubMed
Skrzydlewska, E et al. (2005) Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol. 11: 1251.CrossRefGoogle ScholarPubMed
Abboud-Jarrous, G et al. (2008) Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment. J Biol Chem. 283: 18167.CrossRefGoogle ScholarPubMed
Joyce, JA et al. (2004) Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell. 5: 443.CrossRefGoogle ScholarPubMed
Reddy, VY et al. (1995) Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci U S A 92: 3849.CrossRefGoogle ScholarPubMed
Gocheva, V et al. (2006) Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20: 543.CrossRefGoogle ScholarPubMed
Rousselet, N et al. (2004) Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res. 64: 146.CrossRefGoogle ScholarPubMed
Katunuma, N et al. (2002) Structure-based development of cathepsin L inhibitors and therapeutic applications for prevention of cancer metastasis and cancer-induced osteoporosis. Adv Enzyme Regul. 42: 159.CrossRefGoogle ScholarPubMed
Lah, TT et al. (2000) Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators. Clin Cancer Res. 6: 578.Google ScholarPubMed
Lah, TT et al. (1997) The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease. Pathol Oncol Res. 3: 89.CrossRefGoogle ScholarPubMed
Levicar, N et al. (2002) Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Detect Prev. 26: 42.CrossRefGoogle ScholarPubMed
Dohchin, A et al. (2000) Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer. 89: 482.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Friedrich, B et al. (1999) Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer. 35: 138.CrossRefGoogle ScholarPubMed
Reinheckel, T et al. (2005) The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling. J Cell Sci. 118: 3387.CrossRefGoogle ScholarPubMed
Boudreau, F et al. (2007) Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia. FASEB J. 21: 3853.CrossRefGoogle ScholarPubMed
Walz, M et al. (2007) Expression of the human Cathepsin L inhibitor hurpin in mice: skin alterations and increased carcinogenesis. Exp Dermatol. 16: 715.CrossRefGoogle ScholarPubMed
Brix, K et al. (2008) Cysteine cathepsins: cellular roadmap to different functions. Biochimie. 90: 194.CrossRefGoogle ScholarPubMed
Bromme, D et al. (1993) Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme. J Biol Chem. 268: 4832.Google ScholarPubMed
Gatenby, RA et al. (2006) Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66: 5216.CrossRefGoogle ScholarPubMed
Gillies, RJ et al. (2002) MRI of the tumor microenvironment. J Magn Reson Imaging. 16: 430.CrossRefGoogle ScholarPubMed
Rofstad, EK et al. (2006) Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 66: 6699.CrossRefGoogle ScholarPubMed
Janoff, A, Scherer, J (1968) Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med. 128: 1137.CrossRefGoogle ScholarPubMed
Li, FQ, Horwitz, M (2001) Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem. 276: 14230.CrossRefGoogle ScholarPubMed
Horwitz, M et al. (2003) Role of neutrophil elastase in bone marrow failure syndromes: molecular genetic revival of the chalone hypothesis. Curr Opin Hematol. 10: 49.CrossRefGoogle ScholarPubMed
Horwitz, M et al. (2004) Hereditary neutropenia: dogs explain human neutrophil elastase mutations. Trends Mol Med. 10: 163.CrossRefGoogle ScholarPubMed
Watorek, W et al. (1988) Neutrophil elastase and cathepsin G: structure, function, and biological control. Adv Exp Med Biol. 240: 23.CrossRefGoogle ScholarPubMed
Schmitt, M et al. (1991) Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer. Biomed Biochim Acta. 50: 731.Google Scholar
Dona, M et al. (2004) Hyperforin inhibits cancer invasion and metastasis. Cancer Res. 64: 6225.CrossRefGoogle ScholarPubMed
Inada, M et al. (1998) Complete inhibition of spontaneous pulmonary metastasis of human lung carcinoma cell line EBC-1 by a neutrophil elastase inhibitor (ONO-5046.Na). Anticancer Res. 18: 885.Google Scholar
Nozawa, F et al. (2000) Elastase activity enhances the adhesion of neutrophil and cancer cells to vascular endothelial cells. J Surg Res. 94: 153.CrossRefGoogle ScholarPubMed
Hornebeck, W et al. (1977) Elastogenesis and elastinolytic activity in human breast cancer. Biomedicine. 26: 48.Google ScholarPubMed
Yamashita, J et al. (1995) Free-form neutrophil elastase is an independent marker predicting recurrence in primary breast cancer. J Leukoc Biol. 57: 375.CrossRefGoogle ScholarPubMed
Rilke, F et al. (1991) Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer. 49: 44.CrossRefGoogle ScholarPubMed
Yamashita, JI et al. (1994) Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer. Br J Cancer. 69: 72.CrossRefGoogle ScholarPubMed
Yamashita, J et al. (1996) Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer. Chest. 109: 1328.CrossRefGoogle ScholarPubMed
Cicco, RL et al. (2007) Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression. Mol Carcinog. 46: 654.CrossRefGoogle ScholarPubMed
Leduc, R et al. (1992) Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. J Biol Chem. 267: 14304.Google ScholarPubMed
Vey, M et al. (1994) Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol. 127: 1829.CrossRefGoogle ScholarPubMed
Creemers, JW et al. (1995) Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum. J Biol Chem. 270: 2695.CrossRefGoogle ScholarPubMed
Anderson, ED et al. (1997) Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J. 16: 1508.CrossRefGoogle ScholarPubMed
Konoshita, T et al. (1994) Expression of PC2 and PC1/PC3 in human pheochromocytomas. Mol Cell Endocrinol. 99: 307.CrossRefGoogle ScholarPubMed
Creemers, JW et al. (1992) Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5 kb cDNA. FEBS Lett. 300: 82.CrossRefGoogle ScholarPubMed
Cheng, M et al. (1997) Pro-protein convertase gene expression in human breast cancer. Int J Cancer. 71: 966.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
Bassi, et al. (2001) Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog. 31: 224.CrossRefGoogle ScholarPubMed
Chen, RN et al. (2008) Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines. Endocrinology. 149: 3817.CrossRefGoogle ScholarPubMed
Scamuffa, N et al. (2008) Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest. 118: 352.CrossRefGoogle ScholarPubMed
Ra, HJ, Parks, WC (2007) Control of matrix metalloproteinase catalytic activity. Matrix Biol. 26: 587.CrossRefGoogle ScholarPubMed
Strongin, AY et al. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem. 270: 5331.CrossRefGoogle ScholarPubMed
Cao, J et al. (1996) Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J Biol Chem. 271: 30174.CrossRefGoogle ScholarPubMed
Cirman, T et al. (2004) Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem. 279: 3578.CrossRefGoogle ScholarPubMed
Barry, M et al. (2000) Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol. 20: 3781.CrossRefGoogle ScholarPubMed
Chen, M et al. (2001) Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem. 276: 30724.CrossRefGoogle Scholar
Mandic, A et al. (2002) Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol. 22: 3003.CrossRefGoogle ScholarPubMed
Gil-Parrado, S et al. (2002) Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem. 277: 27217.CrossRefGoogle ScholarPubMed
Guicciardi, ME et al. (2005) Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor alpha-induced hepatocyte apoptosis. Gastroenterology. 129: 269.CrossRefGoogle ScholarPubMed
Stupack, DG et al. (2006) Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 439: 95.CrossRefGoogle ScholarPubMed
Linder, S (2007) The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 17: 107.CrossRefGoogle ScholarPubMed
Cavallo-Medved, D et al. (2005) Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells. J Cell Sci. 118: 1493.CrossRefGoogle ScholarPubMed
Mai, J et al. (2000) Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J Biol Chem. 275: 12806.CrossRefGoogle ScholarPubMed
Eeckhout, Y, Vaes, G (1977) Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J. 166: 21.CrossRefGoogle ScholarPubMed
Murphy, G et al. (1992) Physiological mechanisms for metalloproteinase activation. Matrix Suppl. 1: 224.Google ScholarPubMed
Schmitt, M et al. (1992) Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol Chem Hoppe Seyler. 373: 611.CrossRefGoogle ScholarPubMed
Ugarova, TP et al. (1996) Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin. Biochemistry. 35: 10913.CrossRefGoogle ScholarPubMed
Buck, MR et al. (1992) Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J. 282 (Pt 1): 273.CrossRefGoogle ScholarPubMed
Vasiljeva, O et al. (2006) Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 66: 5242.CrossRefGoogle ScholarPubMed
Borchers, AH et al. (1994) Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res. 213: 143.CrossRefGoogle ScholarPubMed
Behrendt, N et al. (1995) The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol Chem Hoppe Seyler. 376: 269.Google ScholarPubMed
He, Y et al. (2007) Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. Clin Cancer Res 13: 3115.CrossRefGoogle ScholarPubMed
Fink, T et al. (2002) Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood. 99: 2077.CrossRefGoogle ScholarPubMed
Vleminckx, K et al. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66: 107.CrossRefGoogle ScholarPubMed
Perl, AK et al. (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 392: 190.CrossRefGoogle ScholarPubMed
Beavon, IR (2000) The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer. 36: 1607.CrossRefGoogle ScholarPubMed
Noe, V et al. (2001) Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci. 114: 111.Google ScholarPubMed
Guarino, M (2007) Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol. 39: 2153.CrossRefGoogle ScholarPubMed
DiCamillo, SJ et al. (2002) Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin mRNA in lung fibroblasts. J Biol Chem. 277: 18938.CrossRefGoogle ScholarPubMed
Kohri, K et al. (2002) Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol. 283: L531.CrossRefGoogle ScholarPubMed
Travis, J, Salvesen, GS (1983) Human plasma proteinase inhibitors. Annu Rev Biochem. 52: 655.CrossRefGoogle ScholarPubMed
Janoff, A (1985) Elastase in tissue injury. Annu Rev Med 36: 207.CrossRefGoogle ScholarPubMed
Sternlicht, MD et al. (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98: 137.CrossRefGoogle ScholarPubMed
Koop, S et al. (1994) Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 54: 4791.Google Scholar
Henriet, P et al. (1999) Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS. 107: 111.CrossRefGoogle ScholarPubMed
Kruger, A et al. (1998) Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene. 16: 2419.CrossRefGoogle ScholarPubMed
Rifkin, DB et al. (1999) Proteolytic control of growth factor availability. APMIS. 107: 80.CrossRefGoogle Scholar
Hughes, SJ et al. (1998) A novel amplicon at 8p22–23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc Natl Acad Sci USA. 95: 12410.CrossRefGoogle ScholarPubMed
Fernandez, PL et al. (2001) Expression of cathepsins B and S in the progression of prostate carcinoma. Int J Cancer. 95: 51.3.0.CO;2-J>CrossRefGoogle Scholar
Nagler, DK et al. (2004) Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate. 60: 109.CrossRefGoogle ScholarPubMed
Mohamed, MM, Sloane, BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer. 6: 764.CrossRefGoogle Scholar
Quintanilla-Dieck, MJ et al. (2008) Cathepsin K in melanoma invasion. J Invest Dermatol. 128: 2281.CrossRefGoogle ScholarPubMed
Gall, C et al. (2007) A cathepsin K inhibitor reduces breast cancer–induced osteolysis and skeletal tumor burden. Cancer Res. 67: 9894.CrossRefGoogle ScholarPubMed
Brubaker, KD et al. (2003) Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Miner Res. 18: 222.CrossRefGoogle ScholarPubMed
Diamandis, EP (1998) Prostate-specific antigen: its usefulness in clinical medicine. Trends Endocrinol Metab. 9: 310.CrossRefGoogle ScholarPubMed
Narita, D et al. (2008) Prostate-specific antigen may serve as a pathological predictor in breast cancer. Rom J Morphol Embryol. 49: 173.Google ScholarPubMed
Klezovitch, O et al. (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell. 6: 185.CrossRefGoogle ScholarPubMed
Srikantan, V et al. (2002) HEPSIN inhibits cell growth/invasion in prostate cancer cells. Cancer Res. 62: 6812.Google ScholarPubMed
McCawley, LJ et al. (2004) A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res. 64: 6965.CrossRefGoogle ScholarPubMed
Coussens, LM et al. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103: 481.CrossRefGoogle Scholar
Scorilas, A et al. (2001) Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer. 84: 1488.CrossRefGoogle ScholarPubMed
Gorrin-Rivas, MJ et al. (2000) Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. Clin Cancer Res. 6: 1647.Google ScholarPubMed
Hofmann, HS et al. (2005) Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res. 11: 1086.Google ScholarPubMed
Joyce, JA et al. (2005) A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene. 24: 4037.CrossRefGoogle Scholar
Giraudo, E et al. (2004) An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest. 114: 623.CrossRefGoogle ScholarPubMed
Hildenbrand, R et al. (1999) Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue. J Leukoc Biol. 66: 40.CrossRefGoogle ScholarPubMed
Allavena, P et al. (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 66: 1.CrossRefGoogle ScholarPubMed
Payne, AS, Cornelius, (2002) The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol. 118: 915.CrossRefGoogle ScholarPubMed
Kitamura, T, Taketo, MM (2007) Keeping out the bad guys: gateway to cellular target therapy. Cancer Res. 67: 10099.CrossRefGoogle ScholarPubMed
Zins, K et al. (2007) Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. Cancer Res. 67: 1038.CrossRefGoogle ScholarPubMed
Bonfil, RD et al. (2007) Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urol Oncol. 25: 407.CrossRefGoogle ScholarPubMed
Overall, CM, Kleifeld, O (2006) Tumour microenvironment – opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer. 6: 227.CrossRefGoogle ScholarPubMed
Damme, J et al. (2004) Chemokine-protease interactions in cancer. Semin Cancer Biol. 14: 201.CrossRefGoogle Scholar
Doucet, A et al. (2008) Quantitative degradomics analysis of proteolytic post-translational modifications of the cancer proteome. Mol Cell Proteomics. 7: 1925.CrossRefGoogle ScholarPubMed
Joyce, JA (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell. 7: 513.CrossRefGoogle ScholarPubMed
Gocheva, V, Joyce, JA (2007) Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle. 6: 60.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×